ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
95.851,56
-1,39%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Aadi Bioscience Inc (AADI) Börsenkurse

Aadi Bioscience Inc

Aadi Bioscience Inc (AADI)

NASDAQ
3,39
1,07
(46,12%)
Geschlossen 22 Dezember 10:00PM
Verzögert um 15 Minuten
3,03
-0,36
(-10,62%)
Nach Börsenschluss: 1:58AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
3,03
Gebot
2,99
Fragen
3,44
Volumen
9.056.609
2,07 Tagesbereich 3,60
1,21 52-Wochen-Bereich 3,46
Marktkapitalisierung
74,682M
Handelsende
2,32
Handelsbeginn
2,6993
Letzte Trade
3
@
2.99
Letzter Handelszeitpunkt
Finanzvolumen
US$ 23.377.713
VWAP
2,5813
Durchschnittliches Volumen (3 Mio.)
109.645
Ausgegebene Aktien
24.647.392
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,29
Gewinn pro Aktie (EPS)
-2,67
Erlöse
24,35M
Nettogewinn
-65,77M

Über Aadi Bioscience Inc

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other ... Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.aadibio.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Aadi Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AADI. The last closing price for Aadi Bioscience was US$2,32. Over the last year, Aadi Bioscience shares have traded in a share price range of US$ 1,21 to US$ 3,46.

Aadi Bioscience currently has 24.647.392 shares in issue. The market capitalisation of Aadi Bioscience is US$57,18 million. Aadi Bioscience has a price to earnings ratio (PE ratio) of -1.29.

AADI Neueste Nachrichten

Weitere Nachrichten

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

20 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Dezember 2024
Edgar (US Regulatory)

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing PR Newswire LOS ANGELES, Dec. 19, 2024 Aadi Enters into Exclusive...

20 Dezember 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

06 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 November 2024
Edgar (US Regulatory)

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update PR Newswire LOS ANGELES, Nov. 6, 2024 FYARRO® sales of $7.2 million for Q3 2024, reflecting...

06 November 2024
PR Newswire (US)

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update PR Newswire LOS ANGELES, Oct. 30, 2024 LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI...

30 Oktober 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

04 Oktober 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

04 Oktober 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

01 Oktober 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.6326.252.43.462.251349882.34487038CS
40.73532.02614379082.2953.462.171185142.35978253CS
121.1157.81251.923.461.881096452.18108007CS
261.4591.77215189871.583.461.212026581.73559953CS
520.8740.27777777782.163.461.212615391.88264268CS
156-22.08-87.933094384725.1126.21.211824196.18008658CS
260-26.97-89.93032.991.211793267.67024567CS

AADI - Frequently Asked Questions (FAQ)

What is the current Aadi Bioscience share price?
The current share price of Aadi Bioscience is US$ 3,03
How many Aadi Bioscience shares are in issue?
Aadi Bioscience has 24.647.392 shares in issue
What is the market cap of Aadi Bioscience?
The market capitalisation of Aadi Bioscience is USD 57,18M
What is the 1 year trading range for Aadi Bioscience share price?
Aadi Bioscience has traded in the range of US$ 1,21 to US$ 3,46 during the past year
What is the PE ratio of Aadi Bioscience?
The price to earnings ratio of Aadi Bioscience is -1,29
What is the cash to sales ratio of Aadi Bioscience?
The cash to sales ratio of Aadi Bioscience is 3,48
What is the reporting currency for Aadi Bioscience?
Aadi Bioscience reports financial results in USD
What is the latest annual turnover for Aadi Bioscience?
The latest annual turnover of Aadi Bioscience is USD 24,35M
What is the latest annual profit for Aadi Bioscience?
The latest annual profit of Aadi Bioscience is USD -65,77M
What is the registered address of Aadi Bioscience?
The registered address for Aadi Bioscience is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aadi Bioscience website address?
The website address for Aadi Bioscience is www.aadibio.com
Which industry sector does Aadi Bioscience operate in?
Aadi Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
AADI
Aadi Bioscience
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten